(19)
(11)
EP 0 726 777 A1
(12)
(43)
Date of publication:
21.08.1996
Bulletin 1996/34
(21)
Application number:
94932028.0
(22)
Date of filing:
25.10.1994
(51)
International Patent Classification (IPC):
C12N
15/
09
( . )
A61K
38/
00
( . )
A61K
39/
385
( . )
A61P
29/
00
( . )
A61P
43/
00
( . )
C12N
1/
21
( . )
C12P
21/
02
( . )
A61K
9/
127
( . )
A61K
39/
00
( . )
A61P
25/
00
( . )
A61P
37/
00
( . )
C07K
14/
74
( . )
C12N
15/
12
( . )
C12R
1/
19
( . )
(86)
International application number:
PCT/US1994/012231
(87)
International publication number:
WO 1995/011702
(
04.05.1995
Gazette 1995/19)
(84)
Designated Contracting States:
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
(30)
Priority:
25.10.1993
US 19930143575
(71)
Applicant:
ANERGEN, INC.
Redwood City, CA 94063 (US)
(72)
Inventors:
RHODES, Eric T.
Vallejo, CA 94591 (US)
NAG, Bishwajit
Pacifica, CA 94044 (US)
(74)
Representative:
Walton, Seán Malcolm, et al
Mewburn Ellis, York House, 23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)
(54)
PROKARYOTIC EXPRESSION OF MHC PROTEINS